SCHEMBL31672845

SCHEMBL31672845

CCCCC(=O)NC(c1ccc(OC)cc1)c1cc(Cl)c2cccnc2c1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 7/20 0.79
NPC1 O15118 5/20 0.75
RAB9A P51151 5/20 0.75
KMT2A Q03164 4/20 0.75
LMNA P02545 6/20 0.73
HSP90AA1 P07900 5/20 0.73
KDM4E B2RXH2 5/20 0.73
TDP1 Q9NUW8 4/20 0.73
SMN1; SMN2 Q16637 2/20 0.73
MITF O75030 1/20 0.73
POLB P06746 1/20 0.70
TP53 P04637 2/20 0.69
KDM1A O60341 1/20 0.69
MEN1 O00255 2/20 0.68
ALDH1A1 P00352 1/20 0.68
HTT P42858 3/20 0.67
ALOX12 P18054 3/20 0.67
L3MBTL1 Q9Y468 2/20 0.67
GAA P10253 1/20 0.66
HSPA5 P11021 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2153202 1.00 ADAMTS5 (0.79) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL30876659 0.95 ADAMTS5 (0.83) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL24634657 0.95 ADAMTS5 (0.83) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL27768738 0.91 HSP90AA1 (0.71) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL609006 0.91 ADAMTS5 (0.84) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL23792594 0.91 HSP90AA1 (0.75) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL27768660 0.91 HSP90AA1 (0.75) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL2153116 0.90 HSP90AA1 (0.76) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL31533556 0.89 HSP90AA1 (0.66) ADAMTS5NPC1RAB9AKMT2ALMNA
SCHEMBL31533543 0.89 HSP90AA1 (0.68) ADAMTS5NPC1RAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103444-A1 8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF UNIV OSAKA (JP) 2026-04-16 US disclosed
EP-4599832-A1 8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2025-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103444-A1 8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF MYLK2, MYLK, ATP2A1 ADAMTS5 4073/4885NPC1 2505/4885RAB9A 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.